Drug intelligence / Profile preview

Tongmai Jiangzhuo granules

Development stage
Phase 3
Lead developer
First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Tongmai Jiangzhuo granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. It is primarily investigated for the early intervention of preclinical atherosclerosis. The formulation is designed to "unblock vessels" and "reduce turbidity," targeting cardiovascular risk factors and the progression of carotid intima-media thickness (CIMT). In clinical studies, it is evaluated as an adjunct to lifestyle interventions to improve cardiovascular outcomes and metabolic markers. It has been studied in Phase 3 clinical trials in China.

Other names
Tongmai Jiangzhuo Keli
02

Targets

ABCA1 (ATP-binding cassette transporter A1)CD36 (CD36 antigen)NR1H3 (Liver X receptor beta)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Tongmai Jiangzhuo granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongmai Jiangzhuo granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call